DK1496059T3 - Kondenseret bicyklisk pyrimidinderivat - Google Patents

Kondenseret bicyklisk pyrimidinderivat

Info

Publication number
DK1496059T3
DK1496059T3 DK03712828T DK03712828T DK1496059T3 DK 1496059 T3 DK1496059 T3 DK 1496059T3 DK 03712828 T DK03712828 T DK 03712828T DK 03712828 T DK03712828 T DK 03712828T DK 1496059 T3 DK1496059 T3 DK 1496059T3
Authority
DK
Denmark
Prior art keywords
ring
pyrimidine derivative
bicyclic pyrimidine
condensed bicyclic
receptor antagonist
Prior art date
Application number
DK03712828T
Other languages
English (en)
Inventor
Shigeru Izawa
Shigeki Seto
Asao Tanioka
Makoto Ikeda
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of DK1496059T3 publication Critical patent/DK1496059T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK03712828T 2002-03-26 2003-03-24 Kondenseret bicyklisk pyrimidinderivat DK1496059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002084759 2002-03-26
PCT/JP2003/003488 WO2003080619A1 (fr) 2002-03-26 2003-03-24 Derives de pyrimidine bicycliques et fusionnes

Publications (1)

Publication Number Publication Date
DK1496059T3 true DK1496059T3 (da) 2007-12-03

Family

ID=28449223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03712828T DK1496059T3 (da) 2002-03-26 2003-03-24 Kondenseret bicyklisk pyrimidinderivat

Country Status (16)

Country Link
US (1) US7064119B2 (da)
EP (1) EP1496059B1 (da)
JP (1) JP4402959B2 (da)
KR (1) KR20040093182A (da)
CN (1) CN1330654C (da)
AT (1) ATE370140T1 (da)
AU (1) AU2003221205B2 (da)
BR (1) BR0308844A (da)
CA (1) CA2479277A1 (da)
DE (1) DE60315626T2 (da)
DK (1) DK1496059T3 (da)
MX (1) MXPA04009300A (da)
NO (1) NO20044331L (da)
NZ (1) NZ535183A (da)
PT (1) PT1496059E (da)
WO (1) WO2003080619A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686985A2 (en) * 2003-10-27 2006-08-09 Novartis AG Use of neurokinin antagonists in the treatment of urinary incontinence
US8102868B2 (en) * 2006-01-05 2012-01-24 Folusha Forte B.V., Llc Interleaved and directional wireless mesh network
US20070183439A1 (en) * 2006-01-05 2007-08-09 Osann Robert Jr Combined directional and mobile interleaved wireless mesh network
US20070297366A1 (en) * 2006-01-05 2007-12-27 Robert Osann Synchronized wireless mesh network
TW200914457A (en) * 2007-05-31 2009-04-01 Kyowa Hakko Kogyo Kk Pyrimidodiazepinone derivative
CN115368363B (zh) * 2021-05-17 2024-02-20 中山大学 一种手性或消旋的嘧啶并二氮杂环庚酮类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2976097B2 (ja) * 1995-03-24 1999-11-10 武田薬品工業株式会社 環状化合物、その製造法および剤
JP3993264B2 (ja) 1995-03-24 2007-10-17 武田薬品工業株式会社 環状化合物、その製造法および剤
US5770590A (en) 1995-03-24 1998-06-23 Takeda Chemical Industries, Ltd. Cyclic compounds, their prudiction and use
JP2002348289A (ja) 2001-03-19 2002-12-04 Takeda Chem Ind Ltd ３環性複素環化合物、その製造法および用途

Also Published As

Publication number Publication date
EP1496059B1 (en) 2007-08-15
WO2003080619A1 (fr) 2003-10-02
EP1496059A4 (en) 2006-02-08
CN1656098A (zh) 2005-08-17
JP4402959B2 (ja) 2010-01-20
NZ535183A (en) 2006-03-31
NO20044331L (no) 2004-10-25
AU2003221205A1 (en) 2003-10-08
ATE370140T1 (de) 2007-09-15
MXPA04009300A (es) 2005-01-25
EP1496059A1 (en) 2005-01-12
DE60315626T2 (de) 2008-06-05
CN1330654C (zh) 2007-08-08
PT1496059E (pt) 2007-10-29
AU2003221205B2 (en) 2008-09-18
CA2479277A1 (en) 2003-10-02
JPWO2003080619A1 (ja) 2005-07-21
US7064119B2 (en) 2006-06-20
US20050159409A1 (en) 2005-07-21
BR0308844A (pt) 2005-01-04
KR20040093182A (ko) 2004-11-04
DE60315626D1 (de) 2007-09-27

Similar Documents

Publication Publication Date Title
BRPI0414592A (pt) antagonistas de receptores de trombina
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
EA200300595A1 (ru) Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
RS50537B (sr) Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii
NO20064579L (no) Bifenylforbindelser anvendelige som muskariniske receptorantagonister
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
TW200609218A (en) Bicyclic compounds
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
DE60326933D1 (de) Kondensierte bicyclische pyrimidinderivate
EA200501041A1 (ru) Замещенные производные 1-пиперидин-4-ил-4-пирролидин-3-илпиперазина и их применение в качестве антагонистов нейрокининов
PT1129096E (pt) Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DK1496059T3 (da) Kondenseret bicyklisk pyrimidinderivat
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
EA200700179A1 (ru) Производные пиррола, их получение и их применение в терапии
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
IL149838A0 (en) Novel il-8 receptor antagonists
ATE407133T1 (de) 2-imidazo-benzothiazole als adenosin-rezeptor liganden